| Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through beta-catenin by acting as targets of miR-495-3p. | Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p.
Zheng B, Geng Y, Li Y, Huang H, Liu A. | 08/14/2024 |
| MicroRNA-495: a therapeutic and diagnostic tumor marker. | MicroRNA-495: a therapeutic and diagnostic tumor marker.
Maharati A, Tolue Ghasaban F, Akhlaghipour I, Taghehchian N, Zangouei AS, Moghbeli M. | 11/16/2023 |
| Downregulated miR-495-3p in colorectal cancer targets TGFbetaR1, TGFbetaR2, SMAD4 and BUB1 genes and induces cell cycle arrest. | Downregulated miR-495-3p in colorectal cancer targets TGFβR1, TGFβR2, SMAD4 and BUB1 genes and induces cell cycle arrest.
Kabiri F, Medlej A, Saleh AJ, Aghdami N, Khani M, Soltani BM. | 05/30/2023 |
| lncRNA NEAT1/miR-495-3p regulates angiogenesis in burn sepsis through the TGF-beta1 and SMAD signaling pathways. | lncRNA NEAT1/miR-495-3p regulates angiogenesis in burn sepsis through the TGF-β1 and SMAD signaling pathways.
Meng Y, Hao Z, Zhang H, Bai P, Guo W, Tian X, Xu J., Free PMC Article | 02/4/2023 |
| Impact of miR-200b and miR-495 variants on the risk of large-artery atherosclerosis stroke. | Impact of miR-200b and miR-495 variants on the risk of large-artery atherosclerosis stroke.
Qin S, Shen C, Tang W, Wang M, Lin Y, Wang Z, Li Y, Zhang Z, Liu X. | 01/28/2023 |
| CREB1 regulates KPNA2 by inhibiting mir-495-3p transcription to control melanoma progression : The role of the CREB1/miR-495-3p/KPNA2 axis in melanoma progression. | CREB1 regulates KPNA2 by inhibiting mir-495-3p transcription to control melanoma progression : The role of the CREB1/miR-495-3p/KPNA2 axis in melanoma progression.
Geng X, Qiu X, Gao J, Gong Z, Zhou X, Liu C, Luo H., Free PMC Article | 12/24/2022 |
| miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC. | miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC.
Arora S, Singh P, Tabassum G, Dohare R, Syed MA. | 08/27/2022 |
| The Potential of miR-370-3p and miR-495-3p Serving as Biomarkers for Sepsis-Associated Acute Kidney Injury. | The Potential of miR-370-3p and miR-495-3p Serving as Biomarkers for Sepsis-Associated Acute Kidney Injury.
Ma W, Miao X, Xia F, Ruan C, Tao D, Li B., Free PMC Article | 08/6/2022 |
| Circular RNA VMA21 ameliorates IL-1beta-engendered chondrocyte injury through the miR-495-3p/FBWX7 signaling axis. | Circular RNA VMA21 ameliorates IL-1β-engendered chondrocyte injury through the miR-495-3p/FBWX7 signaling axis.
Li Z, Meng D, Liu Y, Bi F, Tian K, Xu J, Sun J, Gu C, Li Y. | 05/21/2022 |
| miR-495-3p depresses cell proliferation and migration by downregulating HMGB1 in colorectal cancer. | miR-495-3p depresses cell proliferation and migration by downregulating HMGB1 in colorectal cancer.
Zhang JL, Zheng HF, Li K, Zhu YP., Free PMC Article | 04/9/2022 |
| Long non-coding RNA MEG8 induced by PLAG1 promotes clear cell renal cell carcinoma through the miR-495-3p/G3BP1 axis. | Long non-coding RNA MEG8 induced by PLAG1 promotes clear cell renal cell carcinoma through the miR-495-3p/G3BP1 axis.
Shan G, Huang T, Tang T. | 03/26/2022 |
| SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis. | SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis.
Li H, Wang D, Yi B, Cai H, Wang Y, Lou X, Xi Z, Li Z., Free PMC Article | 03/19/2022 |
| Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1alpha (HIF-1alpha). | Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α).
Zhang L, Wu H, Zhang Y, Xiao X, Chu F, Zhang L., Free PMC Article | 02/26/2022 |
| Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) promotes the inflammation and apoptosis of otitis media with effusion through targeting microRNA (miR)-495 and activation of p38 MAPK signaling pathway. | Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) promotes the inflammation and apoptosis of otitis media with effusion through targeting microRNA (miR)-495 and activation of p38 MAPK signaling pathway.
Hu Y, Dong H, Huang J, Huang J, Tao D, Huang C, Hu L, Xu H, Sun Y., Free PMC Article | 02/19/2022 |
| MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A. | MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.
Li Z, Li S, Wen Y, Chen J, Liu K, Jia J., Free PMC Article | 02/12/2022 |
| Silencing circBIRC6 inhibits the proliferation, invasion, migration and epithelialmesenchymal transition of bladder cancer cells by targeting the miR4953p/XBP1 signaling axis. | Silencing circ‑BIRC6 inhibits the proliferation, invasion, migration and epithelial‑mesenchymal transition of bladder cancer cells by targeting the miR‑495‑3p/XBP1 signaling axis.
Zhou L, Wang B, Zhang Y, Yao K, Liu B., Free PMC Article | 01/22/2022 |
| MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer. | MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer.
Tang J, Pan H, Wang W, Qi C, Gu C, Shang A, Zhu J. | 01/15/2022 |
| S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification. | S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification.
Jiang PF, Zhang XJ, Song CY, Zhang YX, Wu Y. | 01/8/2022 |
| LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A. | LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A.
Dai BQ, Jiang X, Feng LC. | 01/8/2022 |
| MicroRNA miR-495 regulates the development of Hepatocellular Carcinoma by targeting C1q/tumor necrosis factor-related protein-3 (CTRP3). | MicroRNA miR-495 regulates the development of Hepatocellular Carcinoma by targeting C1q/tumor necrosis factor-related protein-3 (CTRP3).
Zhang R, Guo C, Liu T, Li W, Chen X., Free PMC Article | 01/1/2022 |
| Circ_0114428 Regulates Sepsis-Induced Kidney Injury by Targeting the miR-495-3p/CRBN Axis. | Circ_0114428 Regulates Sepsis-Induced Kidney Injury by Targeting the miR-495-3p/CRBN Axis.
He Y, Sun Y, Peng J. | 12/25/2021 |
| MicroRNA-495/TGF-beta/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells. | MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells.
Kumar U, Hu Y, Masrour N, Castellanos-Uribe M, Harrod A, May ST, Ali S, Speirs V, Coombes RC, Yagüe E. | 11/22/2021 |
| N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis. | N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
Hu N, Ji H., Free PMC Article | 11/13/2021 |
| Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis. | Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis.
Zhou W, Guan W, Zhou Y, Rao Y, Ji X, Li J. | 11/6/2021 |
| Circ_0000215 Increases the Expression of CXCR2 and Promoted the Progression of Glioma Cells by Sponging miR-495-3p. | Circ_0000215 Increases the Expression of CXCR2 and Promoted the Progression of Glioma Cells by Sponging miR-495-3p.
Mutalifu N, Du P, Zhang J, Akbar H, Yan B, Alimu S, Tong L, Luan X., Free PMC Article | 11/6/2021 |